A citation-based method for searching scientific literature

Debra E Lyon, Angela Starkweather, Yingwei Yao, Timothy Garrett, Debra Lynch Kelly, Victoria Menzies, Paweł Dereziński, Susmita Datta, Sreelakshmy Kumar, Colleen Jackson-Cook. Biol Res Nurs 2018
Times Cited: 9







List of co-cited articles
43 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sleep disturbance and kynurenine metabolism in depression.
Hyong Jin Cho, Jonathan Savitz, Robert Dantzer, T Kent Teague, Wayne C Drevets, Michael R Irwin. J Psychosom Res 2017
25
33

Levels in neurotransmitter precursor amino acids correlate with mental health in patients with breast cancer.
K Hüfner, A Oberguggenberger, C Kohl, S Geisler, E Gamper, V Meraner, J Egeter, M Hubalek, B Beer, D Fuchs,[...]. Psychoneuroendocrinology 2015
23
33

C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy.
Maria M Pertl, David Hevey, Noreen T Boyle, Martina M Hughes, Sonya Collier, Anne-Marie O'Dwyer, Andrew Harkin, M John Kennedy, Thomas J Connor. Brain Behav Immun 2013
48
33

Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder.
Jonathan Savitz, Robert Dantzer, Timothy B Meier, Brent E Wurfel, Teresa A Victor, Scott A McIntosh, Bart N Ford, Harvey M Morris, Jerzy Bodurka, T Kent Teague,[...]. Psychoneuroendocrinology 2015
53
22

Trial watch: IDO inhibitors in cancer therapy.
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Catherine Sautès-Fridman, Eric Tartour, Eugene P Kennedy, Michael Platten, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi. Oncoimmunology 2014
159
22


Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression.
Timothy B Meier, Wayne C Drevets, T Kent Teague, Brent E Wurfel, Sven C Mueller, Jerzy Bodurka, Robert Dantzer, Jonathan Savitz. Brain Behav Immun 2018
23
22

Tryptophan-catabolizing enzymes - party of three.
Helen J Ball, Felicita F Jusof, Supun M Bakmiwewa, Nicholas H Hunt, Hajime J Yuasa. Front Immunol 2014
87
22

Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies.
Gislaine Z Réus, Karen Jansen, Stephanie Titus, André F Carvalho, Vilma Gabbay, João Quevedo. J Psychiatr Res 2015
104
22

Diminished quality of life in patients with cancer correlates with tryptophan degradation.
Katharina Schroecksnadel, Michael Fiegl, Karin Prassl, Christiana Winkler, Hubert A Denz, Dietmar Fuchs. J Cancer Res Clin Oncol 2007
36
22

Kynurenine pathway in depression: A systematic review and meta-analysis.
Kamiyu Ogyu, Kaoruhiko Kubo, Yoshihiro Noda, Yusuke Iwata, Sakiko Tsugawa, Yuki Omura, Masataka Wada, Ryosuke Tarumi, Eric Plitman, Sho Moriguchi,[...]. Neurosci Biobehav Rev 2018
88
22

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.
Lucile Capuron, Gabriele Neurauter, Dominique L Musselman, David H Lawson, Charles B Nemeroff, Dietmar Fuchs, Andrew H Miller. Biol Psychiatry 2003
319
22

Cancer-Related Fatigue, Version 2.2015.
Ann M Berger, Kathi Mooney, Amy Alvarez-Perez, William S Breitbart, Kristen M Carpenter, David Cella, Charles Cleeland, Efrat Dotan, Mario A Eisenberger, Carmen P Escalante,[...]. J Natl Compr Canc Netw 2015
279
22

Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue.
Sangmi Kim, Brian J Miller, Michael E Stefanek, Andrew H Miller. Cancer 2015
36
22

Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status.
Arthur R Van Gool, Robert Verkerk, Durk Fekkes, Marjolein Bannink, Stefan Sleijfer, Wim H J Kruit, Bronno van der Holt, Simon Scharpé, Alexander M M Eggermont, Gerrit Stoter,[...]. Psychiatry Clin Neurosci 2008
18
22

A biological basis for depression in pancreatic cancer.
Isadora C Botwinick, Lisa Pursell, Gary Yu, Tom Cooper, J John Mann, John A Chabot. HPB (Oxford) 2014
23
22

Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder.
Jonathan Savitz, Wayne C Drevets, Brent E Wurfel, Bart N Ford, Patrick S F Bellgowan, Teresa A Victor, Jerzy Bodurka, T Kent Teague, Robert Dantzer. Brain Behav Immun 2015
111
22

Understanding the role of the kynurenine pathway in human breast cancer immunobiology.
Benjamin Heng, Chai K Lim, David B Lovejoy, Alban Bessede, Laurence Gluch, Gilles J Guillemin. Oncotarget 2016
73
22

Interferon-alpha influences tryptophan metabolism without inducing psychiatric side effects.
Marjolein Bannink, Durk Fekkes, Arthur R Van Gool, Wim H J Kruit, Stefan Sleijfer, Bronno van der Holt, Alexander M M Eggermont, Gerrit Stoter, Michiel W Hengeveld. Neuropsychobiology 2007
15
22

Metabolic Footprints and Molecular Subtypes in Breast Cancer.
Vera Cappelletti, Egidio Iorio, Patrizia Miodini, Marco Silvestri, Matteo Dugo, Maria Grazia Daidone. Dis Markers 2017
26
22

Nutritional metabolomics and breast cancer risk in a prospective study.
Mary C Playdon, Regina G Ziegler, Joshua N Sampson, Rachael Stolzenberg-Solomon, Henry J Thompson, Melinda L Irwin, Susan T Mayne, Robert N Hoover, Steven C Moore. Am J Clin Nutr 2017
70
22

Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles.
Masahiro Sugimoto, David T Wong, Akiyoshi Hirayama, Tomoyoshi Soga, Masaru Tomita. Metabolomics 2010
493
22

Volatile metabolomic signature of human breast cancer cell lines.
Catarina L Silva, Rosa Perestrelo, Pedro Silva, Helena Tomás, José S Câmara. Sci Rep 2017
28
22

Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
Yong Fan, Xin Zhou, Tian-Song Xia, Zhuo Chen, Jin Li, Qun Liu, Raphael N Alolga, Yan Chen, Mao-De Lai, Ping Li,[...]. Oncotarget 2016
49
22

NMR metabolomic signatures reveal predictive plasma metabolites associated with long-term risk of developing breast cancer.
Lucie Lécuyer, Agnès Victor Bala, Mélanie Deschasaux, Nadia Bouchemal, Mohamed Nawfal Triba, Marie-Paule Vasson, Adrien Rossary, Aicha Demidem, Pilar Galan, Serge Hercberg,[...]. Int J Epidemiol 2018
25
22

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
22

A dried blood spot mass spectrometry metabolomic approach for rapid breast cancer detection.
Qingjun Wang, Tao Sun, Yunfeng Cao, Peng Gao, Jun Dong, Yanhua Fang, Zhongze Fang, Xiaoyu Sun, Zhitu Zhu. Onco Targets Ther 2016
33
22

Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism.
Jan Budczies, Scarlet F Brockmöller, Berit M Müller, Dinesh K Barupal, Christiane Richter-Ehrenstein, Anke Kleine-Tebbe, Julian L Griffin, Matej Orešič, Manfred Dietel, Carsten Denkert,[...]. J Proteomics 2013
97
22


Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancer.
Bàrbara Roig, Marta Rodríguez-Balada, Sara Samino, Eric W-F Lam, Sandra Guaita-Esteruelas, Ana R Gomes, Xavier Correig, Joan Borràs, Oscar Yanes, Josep Gumà. Sci Rep 2017
20
22

Centering, scaling, and transformations: improving the biological information content of metabolomics data.
Robert A van den Berg, Huub C J Hoefsloot, Johan A Westerhuis, Age K Smilde, Mariët J van der Werf. BMC Genomics 2006
22

Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences.
Fariba Tayyari, G A Nagana Gowda, Olufunmilayo F Olopade, Richard Berg, Howard H Yang, Maxwell P Lee, Wilfred F Ngwa, Suresh K Mittal, Daniel Raftery, Sulma I Mohammed. Oncotarget 2018
26
22

Screening of salivary volatiles for putative breast cancer discrimination: an exploratory study involving geographically distant populations.
Carina Cavaco, Jorge A M Pereira, Khushman Taunk, Ravindra Taware, Srikanth Rapole, Hampapathalu Nagarajaram, José S Câmara. Anal Bioanal Chem 2018
17
22

Urinary metabolite and lipid alterations in Colombian Hispanic women with breast cancer: A pilot study.
Mónica Cala, Julian Aldana, Julián Sánchez, José Guio, Roland J W Meesters. J Pharm Biomed Anal 2018
19
22

Diagnostic approach to breast cancer patients based on target metabolomics in saliva by liquid chromatography with tandem mass spectrometry.
Takahiro Takayama, Haruhito Tsutsui, Ippei Shimizu, Tatsuya Toyama, Nobuyasu Yoshimoto, Yumi Endo, Koichi Inoue, Kenichiro Todoroki, Jun Zhe Min, Hajime Mizuno,[...]. Clin Chim Acta 2016
42
22

A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk.
Steven C Moore, Mary C Playdon, Joshua N Sampson, Robert N Hoover, Britton Trabert, Charles E Matthews, Regina G Ziegler. J Natl Cancer Inst 2018
40
22

Metabolomics: an emerging but powerful tool for precision medicine.
Clary B Clish. Cold Spring Harb Mol Case Stud 2015
121
22

Metabolomics in breast cancer: A decade in review.
Amelia McCartney, Alessia Vignoli, Laura Biganzoli, Richard Love, Leonardo Tenori, Claudio Luchinat, Angelo Di Leo. Cancer Treat Rev 2018
50
22

Anthropometric measures and serum estrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study.
Hannah Oh, Sally B Coburn, Charles E Matthews, Roni T Falk, Erin S LeBlanc, Jean Wactawski-Wende, Joshua Sampson, Ruth M Pfeiffer, Louise A Brinton, Nicolas Wentzensen,[...]. Breast Cancer Res 2017
11
22

Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy.
Yihan Sun, Jae Hyun Kim, Kiran Vangipuram, Daniel F Hayes, Ellen M L Smith, Larisa Yeomans, N Lynn Henry, Kathleen A Stringer, Daniel L Hertz. Breast Cancer Res Treat 2018
17
22

Innovation: Metabolomics: the apogee of the omics trilogy.
Gary J Patti, Oscar Yanes, Gary Siuzdak. Nat Rev Mol Cell Biol 2012
22


Metabolomics Reveals Protection of Resveratrol in Diet-Induced Metabolic Risk Factors in Abdominal Muscle.
Guoyou Chen, Guozhu Ye, Xinbo Zhang, Xiaoxiao Liu, Yingfeng Tu, Zengjie Ye, Jincheng Liu, Qi Guo, Zhiguo Wang, Lin Wang,[...]. Cell Physiol Biochem 2018
7
28

The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment.
Madhav D Sharma, Rahul Shinde, Tracy L McGaha, Lei Huang, Rikke B Holmgaard, Jedd D Wolchok, Mario R Mautino, Esteban Celis, Arlene H Sharpe, Loise M Francisco,[...]. Sci Adv 2015
91
11

Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.
Carlo Breda, Korrapati V Sathyasaikumar, Shama Sograte Idrissi, Francesca M Notarangelo, Jasper G Estranero, Gareth G L Moore, Edward W Green, Charalambos P Kyriacou, Robert Schwarcz, Flaviano Giorgini. Proc Natl Acad Sci U S A 2016
67
11


Metabotropic glutamate receptors: from the workbench to the bedside.
F Nicoletti, J Bockaert, G L Collingridge, P J Conn, F Ferraguti, D D Schoepp, J T Wroblewski, J P Pin. Neuropharmacology 2011
397
11

Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation.
Erik Kwidzinski, Jörg Bunse, Orhan Aktas, Daniel Richter, Leman Mutlu, Frauke Zipp, Robert Nitsch, Ingo Bechmann. FASEB J 2005
224
11

Aryl hydrocarbon receptor control of a disease tolerance defence pathway.
Alban Bessede, Marco Gargaro, Maria T Pallotta, Davide Matino, Giuseppe Servillo, Cinzia Brunacci, Silvio Bicciato, Emilia M C Mazza, Antonio Macchiarulo, Carmine Vacca,[...]. Nature 2014
378
11

The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment.
Allison B Gold, Nathan Herrmann, Walter Swardfager, Sandra E Black, Richard I Aviv, Gayla Tennen, Alexander Kiss, Krista L Lanctôt. J Neuroinflammation 2011
55
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.